PINC vs SHC: fair value comparison
Premier, Inc. and Sotera Health Company · Updated 2026-10-19
PINC has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, PINC currently ranks higher by quality score.
| PINC | SHC | |
|---|---|---|
| Verdict | No estimate yet | Fairly valued |
| Last price | $49.24 | $17.89 |
| 12-month range | $49.05–$49.80 | $13.13–$19.57 |
| Rank by discount to fair value | — | #49 of 108 Healthcare |
| Rank by quality score | #115 of 301 Healthcare | #116 of 301 Healthcare |
| Quality grade | C | C |
| Leverage | Low | High |
| Margin trend | Expanding | Stable |
| Revenue growth | Declining | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | Mixed |
| 52-week position | The lower-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: PINC fair value analysis · SHC fair value analysis